United Guardian Inc (UG) 15.01 $UG 25.0% Return Seen to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
United Guardian Inc (UG) 15.01 $UG

25.0% Return Seen to Date on SmarTrend United-Guardian Call (UG)
Comtex SmarTrend(R) - Fri Sep 02, 1:27PM CDT
SmarTrend identified a Downtrend for United-Guardian (NASDAQ:UG) on April 5th, 2016 at $20.23. In approximately 5 months, United-Guardian has returned 24.99% as of today's recent price of $15.17.
UG: 15.01 (-0.16)

United-Guardian Shares Down 29.1% Since SmarTrend's Sell Call (UG)
Comtex SmarTrend(R) - Thu Aug 18, 12:57PM CDT
SmarTrend identified a Downtrend for United-Guardian (NASDAQ:UG) on April 5th, 2016 at $20.23. In approximately 5 months, United-Guardian has returned 29.10% as of today's recent price of $14.34.
UG: 15.01 (-0.16)

United-Guardian Reports Second Quarter Financial Results
GlobeNewswire - Tue Aug 09, 11:01AM CDT
United-Guardian, Inc. (NASDAQ:UG) today reported second quarter net income of $405,381 ($0.09 per share) on sales of $2,139,165, and net income of $930,472 ($0.20 per share) on sales of $4,401,741 for the first half of 2016. The decreases from last year's second quarter and first half were not unexpected based upon previous information that had been released by the company.
UG: 15.01 (-0.16)

32.3% Return Seen to Date on SmarTrend United-Guardian Call (UG)
Comtex SmarTrend(R) - Wed Aug 03, 12:49PM CDT
SmarTrend identified a Downtrend for United-Guardian (NASDAQ:UG) on April 5th, 2016 at $20.23. In approximately 4 months, United-Guardian has returned 32.35% as of today's recent price of $13.68.
UG: 15.01 (-0.16)

United-Guardian Announces Mid-Year Dividend
GlobeNewswire - Fri May 20, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) announced today that the company's Board of Directors, at its meeting on May 18, 2016, declared a cash dividend of $0.35 per share, to be paid on June 15, 2016 to all stockholders of record as of the close of business on June 1, 2016. This will be the 21 consecutive year that the company has paid a dividend.
UG: 15.01 (-0.16)

United-Guardian Reports First Quarter Results
GlobeNewswire - Fri May 13, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) reported today that, as expected, net sales for the first quarter of 2016 were down compared with last year's first quarter, decreasing from $4,372,393 in 2015 to $2,262,576 in the first quarter of 2016. As a result, net income decreased from $1,460,510 ($0.32 per share) in the first quarter of 2015 to $525,091 ($0.11 per share) for the first quarter of 2016.
UG: 15.01 (-0.16)

United-Guardian Receives FDA Approval to Market New Single-Dose Form of Renacidin(R)
GlobeNewswire - Mon Jan 04, 8:00AM CST
United-Guardian, Inc. (NASDAQ:UG) announced today that it has received FDA approval of its Supplemental New Drug Application to market a new single-dose form of Renacidin (Citric Acid, Glucono delta-Lactone, and Magnesium Carbonate), the company's proprietary irrigating solution that is used to prevent and dissolve calcifications in indwelling catheters. The newly-approved drug product will be supplied in a 30mL single-use plastic bottle, and will replace the company's 500mL glass bottle. The company expects to have the new product available for distribution in March or April 2016.
UG: 15.01 (-0.16)

United-Guardian Announces Year-End Dividend
GlobeNewswire - Fri Nov 20, 8:00AM CST
United-Guardian, Inc. (Nasdaq:UG) announced today that its Board of Directors, at its meeting on November 18, 2015, declared a cash dividend of $0.50 per share, payable on December 15, 2015 to all stockholders of record on December 1, 2015. This brings to $1.00 per share the dividends the company has paid to its stockholders this year.
UG: 15.01 (-0.16)

United-Guardian posts 3Q profit
Automated Insights - Mon Nov 09, 8:13AM CST
HAUPPAUGE, N.Y. (AP) _ United-Guardian Inc. (UG) on Monday reported third-quarter earnings of $1.2 million.
UG: 15.01 (-0.16)

United-Guardian Reports Strong Third Quarter Results
GlobeNewswire - Mon Nov 09, 8:00AM CST
United-Guardian, Inc. (NASDAQ:UG) reported today that sales for the third quarter of 2015 increased by 44%, and net income increased by almost 200%, compared with the same period last year. Sales for the three-month period were $3,620,365, compared with $2,516,620 for the third quarter of 2014. Net income for the three-month period increased to $1,217,537 ($0.26 per share) from $411,426 ($0.09 per share) for the same period in 2014. For the nine months ended September 30, 2015 sales increased to $12,116,849 as compared with $9,456,248 for the same period last year (an increase of 28%), and net income increased to $4,188,558 ($0.91 per share) from $2,648,452 ($0.58 per share) in 2014, a 58% increase.
UG: 15.01 (-0.16)

United-Guardian Reports Record Six Month Financial Results
GlobeNewswire - Tue Aug 11, 8:00AM CDT
United-Guardian, Inc. (NASDAQ:UG) reported today that sales for the second quarter of 2015 increased by 38% over the same period last year, resulting in a 68% increase in net income compared with the second quarter of 2014. Sales for the quarter increased from $2,980,136 in 2014 to $4,124,091 this year, and net income increased from $901,273 ($0.20 per share) in 2014 to $1,510,511 ($0.33 per share) this year, resulting in the strongest second quarter in the company's history. For the first six months of 2015 sales increased 22% from $6,939,628 in 2014 to $8,496,484 this year, and net income increased 33% from $2,237,026 ($0.49 per share) to $2,971,021 ($0.65 per share), both new company records.
UG: 15.01 (-0.16)

United-Guardian Has Returned 12.5% Since SmarTrend Recommendation (UG)
Comtex SmarTrend(R) - Thu Jun 04, 9:39AM CDT
SmarTrend identified an Uptrend for United-Guardian (NASDAQ:UG) on May 20th, 2015 at $20.28. In approximately 2 weeks, United-Guardian has returned 12.50% as of today's recent price of $22.81.
UG: 15.01 (-0.16)

United-Guardian Announces Increase in Mid-Year Dividend
GlobeNewswire - Fri May 15, 8:00AM CDT
United-Guardian, Inc. (Nasdaq:UG) announced today that the company's Board of Directors, at its meeting on May 13, 2015, declared a cash dividend of $0.50 per share, a 4% increase over last year's mid-year dividend, and a 56% increase over the year-end dividend the company paid in the second half of 2014. It also equals the largest semi-annual dividend the company has ever paid. The dividend will be paid on June 15, 2015 to all stockholders of record as of the close of business on June 1, 2015. This will be the 20 consecutive year that the company has paid a dividend.
UG: 15.01 (-0.16)

Consumer Goods Sector in Focus: Complementary Research on DT Asia Investments, Zuoan Fashion, Embotelladora Andina, G. Willi-Food International, and United-Guardian Inc.
PR Newswire - Fri May 15, 7:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CADT: 6.04 (-1.20), ZA: 1.40 (-0.01), AKO.B: 22.06 (+0.53), UG: 15.01 (-0.16), WILC: 5.75 (-0.03)

United-Guardian Reports Record First Quarter Sales
GlobeNewswire - Wed May 06, 12:00PM CDT
United-Guardian, Inc. (Nasdaq:UG) reported today that sales in the first quarter of 2015 were the strongest of any first quarter in its history, and were just short of its best performing quarter ever. Net sales for the quarter increased by 10.4% compared with the first quarter of 2014, and earnings were up by 9%, resulting in an increase in earnings per share from $0.29 in 2014 to $0.32 this year.
UG: 15.01 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 225

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 466

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 0

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 0

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 349

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 277

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 284

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading

Top 5 Most Recently Viewed Articles

Lawsuit Filed Alleging Eye Injury from Ozempic Use

Updated Category News Views 165

Parker Waichman LLP Takes Action Against Drug Manufacturer Parker Waichman, a prominent national law firm, is actively filing lawsuits for individuals who assert that they developed NAION after using Novo Nordisk's medications, Ozempic or Wegovy. The firm recently initiated a case for a Florida resident who experienced this severe eye condition after using Ozempic....

Continue Reading
C.H. Robinson Prepares for Upcoming Earnings Conference Call

Updated Category News Views 151

C.H. Robinson's Upcoming Earnings Release and Conference Call C.H. Robinson Worldwide, Inc. (Nasdaq: CHRW), a leading logistics provider, has announced significant plans for its upcoming earnings release. The company is scheduled to share its third quarter 2024 results post market close. On this important day, the company will hold a conference call to delve into the...

Continue Reading
PayPal Surges 14% After Exciting Partnership with OpenAI

Updated Category News Views 173

PayPal's Innovative Partnership with OpenAI Shares of PayPal Holdings Inc (NASDAQ: PYPL) experienced a notable increase of 14.38% in pre-market trading. This rise was sparked by the recent announcement of a deal between the payments giant and OpenAI. This partnership focuses on integrating PayPal's digital wallet into the popular AI platform, ChatGPT. Enabling...

Continue Reading
Unlocking the Future of Ridesharing: Uber and Nvidia's Game Changer

Updated Category News Views 199

Introduction to the Partnership In an exciting development, Uber Technologies Inc (NYSE: UBER) has announced a strategic partnership with Nvidia Corp (NASDAQ: NVDA) aimed at leveraging artificial intelligence (AI) to enhance ridesharing and autonomous vehicle technology. Analyst Justin Post from BofA Securities has enthusiastically maintained a Buy rating on Uber’s...

Continue Reading
Exploring the Future of Organic Infant Formula Market Growth

Updated Category News Views 275

Overview of Organic Infant Formula Market Growth The Organic Infant Formula market has seen remarkable expansion, indicating a shift in parental preferences towards health-conscious choices for their young ones. The market, which had a valuation of USD 20.8 billion in the recent past, is expected to reach an impressive USD 36.04 billion by 2032. This growth trajectory...

Continue Reading